
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Strict control of awake blood pressures (BP), ie, clinic BP and home BP measured in the morning and evening, would be effective for reducing the risk of
A comprehensive review article published in Hypertension summarizes the clinical implications of night-time




